Literature DB >> 21429685

Morphologic and functional scoring of cystic fibrosis lung disease using MRI.

Monika Eichinger1, Daiva-Elzbieta Optazaite, Annette Kopp-Schneider, Christian Hintze, Jürgen Biederer, Anne Niemann, Marcus A Mall, Mark O Wielpütz, Hans-Ulrich Kauczor, Michael Puderbach.   

Abstract

Magnetic resonance imaging (MRI) gains increasing importance in the assessment of cystic fibrosis (CF) lung disease. The aim of this study was to develop a morpho-functional MR-scoring-system and to evaluate its intra- and inter-observer reproducibility and clinical practicability to monitor CF lung disease over a broad severity range from infancy to adulthood. 35 CF patients with broad age range (mean 15.3 years; range 0.5-42) were examined by morphological and functional MRI. Lobe based analysis was performed for parameters bronchiectasis/bronchial-wall-thickening, mucus plugging, abscesses/sacculations, consolidations, special findings and perfusion defects. The maximum global score was 72. Two experienced radiologists scored the images at two time points (interval 10 weeks). Upper and lower limits of agreement, concordance correlation coefficients (CCC), total deviation index and coverage probability were calculated for global, morphology, function, component and lobar scores. Global scores ranged from 6 to 47. Intra- and inter-reader agreement for global scores were good (CCC: 0.98 (R1), 0.94 (R2), 0.97 (R1/R2)) and were comparable between high and low scores. Our results indicate that the proposed morpho-functional MR-scoring-system is reproducible and applicable for semi-quantitative evaluation of a large spectrum of CF lung disease severity. This scoring-system can be applied for the routine assessment of CF lung disease and maybe as endpoint for clinical trials.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21429685     DOI: 10.1016/j.ejrad.2011.02.045

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  40 in total

Review 1.  Ten years of chest MRI for patients with cystic fibrosis : Translation from the bench to clinical routine.

Authors:  Patricia Leutz-Schmidt; Monika Eichinger; Mirjam Stahl; Olaf Sommerburg; Jürgen Biederer; Hans-Ulrich Kauczor; Michael U Puderbach; Marcus A Mall; Mark O Wielpütz
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

2.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

3.  Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis.

Authors:  Christina Amaxopoulou; Ralph Gnannt; Kai Higashigaito; Andreas Jung; Christian J Kellenberger
Journal:  Pediatr Radiol       Date:  2017-11-15

4.  Simultaneous MRI of lung structure and perfusion in a single breathhold.

Authors:  Laura C Bell; Kevin M Johnson; Sean B Fain; Andrew Wentland; Randi Drees; Rebecca A Johnson; Grzegorz Bauman; Christopher J Francois; Scott K Nagle
Journal:  J Magn Reson Imaging       Date:  2013-12-20       Impact factor: 4.813

5.  Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosis.

Authors:  Jennifer L Goralski; Sang Hun Chung; Tyler M Glass; Agathe S Ceppe; Esther O Akinnagbe-Zusterzeel; Aaron T Trimble; Richard C Boucher; Brian J Soher; H Cecil Charles; Scott H Donaldson; Yueh Z Lee
Journal:  JCI Insight       Date:  2020-01-30

Review 6.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

7.  Ultrashort Echo-Time Magnetic Resonance Imaging Is a Sensitive Method for the Evaluation of Early Cystic Fibrosis Lung Disease.

Authors:  David J Roach; Yannick Crémillieux; Robert J Fleck; Alan S Brody; Suraj D Serai; Rhonda D Szczesniak; Stephanie Kerlakian; John P Clancy; Jason C Woods
Journal:  Ann Am Thorac Soc       Date:  2016-11

8.  [Specific characteristics of chest X‑ray in childhood : Basics for radiologists].

Authors:  K Schneider
Journal:  Radiologe       Date:  2018-04       Impact factor: 0.635

9.  Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.

Authors:  Simon Y Graeber; Zhe Zhou-Suckow; Jolanthe Schatterny; Stephanie Hirtz; Richard C Boucher; Marcus A Mall
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

Review 10.  Novel end points for clinical trials in young children with cystic fibrosis.

Authors:  Shannon J Simpson; Lauren S Mott; Charles R Esther; Stephen M Stick; Graham L Hall
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.